TLR9 and metabolic dysfunction-associated steatotic liver disease: Given that the TLR4, TLR9 and cGAS-STING signaling pathway is activated under obesity conditions in NAFLD patients and mouse models, it is tempting to speculate that TLRs and cGAS-STING contribute to increased inflammation in the progression of NAFLD to NASH.